FDA Nominee Marty Makary to Face Grilling Over Cutbacks and Policy Shifts

Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines. Appointments and Executive Changes, Regulation and Deregulation of Industry, Drugs (Pharmaceuticals), Food and Drug Administration, Makary, Marty, Trump, Donald J, Presidential Transition (US) Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines. NYT > Business

Leave a Reply

Your email address will not be published. Required fields are marked *